ROS prioritizes patient education, transparency, and the ethical application of peptide therapy, offering treatments backed by scientific research and clinical experience
It is currently completing Phase 3 TRIUMPH trials and is available for research use in lyophilized (freeze-dried powder) form for the latest on [when retatrutide will be FDA approved](/guides/retatrutide-fda-approval-2026-timeline-status), see our regulatory timeline tracker
Community reports suggest the combination produces approximately 60% better outcomes than either peptide alone for significant injuries
For example, those with severe deficiencies might need 1,000 mcg weekly, while others might only need 100 mcg monthly
Otherssuch as shots aimed at hair, skin, or metabolic supportmay take a few days to reach full effect